Related Experiment Video
Updated: Sep 18, 2025
07:24
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.8K
Pharmacy students' knowledge of sickle cell disease
Jasmin C Rose1, Blessing I Okoye2, Ayobami A Aiyeolemi2
1Department of Chemistry, Prairie View A&M University, 700 University Dr Prairie View, TX 77446, USA.
Currents in Pharmacy Teaching & Learning
|June 20, 2025
Summary
Pharmacy students demonstrate suboptimal knowledge of sickle cell disease (SCD), particularly in pharmaceutical treatments. Educational interventions are recommended to improve care for individuals with SCD.
Area of Science:
- Pharmacology
- Hematology
- Medical Education
Background:
- Pharmacists play a crucial role in managing sickle cell disease (SCD) due to recent treatment advancements.
- Optimal SCD care necessitates comprehensive knowledge among pharmacy students.
- Current understanding of pharmacy students' SCD knowledge is limited.
Purpose of the Study:
- To assess the current level of SCD knowledge among pharmacy students.
- To identify associations between sociodemographic factors, prior SCD exposure, and SCD knowledge.
Main Methods:
- A cross-sectional study surveyed 400 pharmacy students at a Central Texas university.
- A 39-item survey assessed SCD knowledge (0-100 scale).
- Descriptive and inferential statistics were used for data analysis.
Main Results:
- A 27% response rate yielded 108 valid surveys.
- Overall mean SCD knowledge score was 43.0 ± 19.2, indicating suboptimal understanding.
- Knowledge was lowest in pharmaceutical treatment (32.6 ± 28.2) and highest in pain management (67.6 ± 31.7).
- Factors associated with knowledge included race/ethnicity, academic year, and prior SCD exposure.
Conclusions:
- Pharmacy students exhibit inadequate knowledge of SCD, especially concerning pharmaceutical treatments.
- Integrating and reinforcing SCD content in pharmacy curricula is essential.
- Targeted educational strategies can enhance preparedness for caring for patients with SCD.
Related Concept Videos
01:49Multiple Allele Traits
35.0K
The Concept of Multiple Allelism
35.0K
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
836
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
836
01:24Chronic Kidney Disease II: Clinical Manifestations
107
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
107
01:30Drug Binding to Blood Components
272
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
272
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.6K